SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc. today announced the appointment of Frank H. Valone, M.D., as Chief Medical Officer. Dr. Valone brings more than 14 years of biotechnology industry experience in the leadership of clinical and preclinical development, medical and regulatory affairs, and quality assurance and control.
